Literature DB >> 9865936

Localization of a novel inositol 1,4,5-trisphosphate binding protein, p130 in rat brain.

M Matsuda1, T Kanematsu, H Takeuchi, T Kukita, M Hirata.   

Abstract

We have isolated a novel inositol 1,4,5-trisphosphate binding protein with molecular mass of 130 kDa (p130), homologous to phospholipase C-delta1 in amino acid sequence but with no catalytic activity. Here we report the expression and localization of p130 at the mRNA level in rat brain. Northern blotting showed that gene expression encoding p130 was most abundant in brain. Brain localization of p130-mRNA using an in situ hybridization technique revealed that in the cerebellum, the mRNA was detected in the granular cell and Purkinje cell layers, and cerebellar nuclei. In the cerebrum, the mRNA was localized in hippocampal pyramidal cells, dentate granule cells and pyramidal and/or granule cells of the cerebral cortex. The brain localization of p130-mRNA was similar to that of the beta-subtype of phospholipase C, indicating that p130 may be mainly involved in phospholipase Cbeta-mediated signaling.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9865936     DOI: 10.1016/s0304-3940(98)00810-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  Involvement of PRIP, phospholipase C-related, but catalytically inactive protein, in bone formation.

Authors:  Koshiro Tsutsumi; Miho Matsuda; Miho Kotani; Akiko Mizokami; Ayako Murakami; Ichiro Takahashi; Yoshihiro Terada; Takashi Kanematsu; Kiyoko Fukami; Tadaomi Takenawa; Eijiro Jimi; Masato Hirata
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

2.  Phospholipase C-related but catalytically inactive protein is required for insulin-induced cell surface expression of gamma-aminobutyric acid type A receptors.

Authors:  Makoto Fujii; Takashi Kanematsu; Hitoshi Ishibashi; Kiyoko Fukami; Tadaomi Takenawa; Keiichi I Nakayama; Stephen J Moss; Junichi Nabekura; Masato Hirata
Journal:  J Biol Chem       Date:  2009-12-07       Impact factor: 5.157

3.  Role of the PLC-related, catalytically inactive protein p130 in GABA(A) receptor function.

Authors:  Takashi Kanematsu; Il-Sung Jang; Taku Yamaguchi; Hiroyasu Nagahama; Kenji Yoshimura; Kiyoshi Hidaka; Miho Matsuda; Hiroshi Takeuchi; Yoshio Misumi; Keiko Nakayama; Tsuneyuki Yamamoto; Norio Akaike; Masato Hirata; Kei-Ichi Nakayama
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

4.  Inhibition of Ca(2+) signalling by p130, a phospholipase-C-related catalytically inactive protein: critical role of the p130 pleckstrin homology domain.

Authors:  H Takeuchi; M Oike; H F Paterson; V Allen; T Kanematsu; Y Ito; C Erneux; M Katan; M Hirata
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

Review 5.  Phosphoinositides: tiny lipids with giant impact on cell regulation.

Authors:  Tamas Balla
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

6.  Phenotypes of pain behavior in phospholipase C-related but catalytically inactive protein type 1 knockout mice.

Authors:  Keisuke Migita; Masahiko Tomiyama; Junko Yamada; Masashi Fukuzawa; Takashi Kanematsu; Masato Hirata; Shinya Ueno
Journal:  Mol Pain       Date:  2011-10-18       Impact factor: 3.395

7.  Progesterone-Dependent Induction of Phospholipase C-Related Catalytically Inactive Protein 1 (PRIP-1) in Decidualizing Human Endometrial Stromal Cells.

Authors:  Joanne Muter; Paul J Brighton; Emma S Lucas; Lauren Lacey; Anatoly Shmygol; Siobhan Quenby; Andrew M Blanks; Jan J Brosens
Journal:  Endocrinology       Date:  2016-05-11       Impact factor: 4.736

Review 8.  Phospholipase C-related catalytically inactive protein can regulate obesity, a state of peripheral inflammation.

Authors:  Yosuke Yamawaki; Kana Oue; Satomi Shirawachi; Satoshi Asano; Kae Harada; Takashi Kanematsu
Journal:  Jpn Dent Sci Rev       Date:  2016-06-27

9.  Tumor Cell "Slimming" Regulates Tumor Progression through PLCL1/UCP1-Mediated Lipid Browning.

Authors:  Zhiyong Xiong; Wen Xiao; Lin Bao; Wei Xiong; Haibing Xiao; Yan Qu; Changfei Yuan; Hailong Ruan; Qi Cao; Keshan Wang; Zhengshuai Song; Cheng Wang; Wenjun Hu; Zeyuan Ru; Junwei Tong; Gong Cheng; Tianbo Xu; Xiangui Meng; Jian Shi; Zhixian Chen; Hongmei Yang; Ke Chen; Xiaoping Zhang
Journal:  Adv Sci (Weinh)       Date:  2019-03-25       Impact factor: 16.806

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.